Biocompatibility study of tobacco mosaic virus nanoparticles on human alveolar bone cells

One of the most important factors in a dental implant's success is an adequate quantity of supporting bone. However, there are still some limitations for the bone substitution material. Previous studies found that tobacco mosaic virus (TMV) had the potential for bone formation induction. The ai...

Full description

Saved in:
Bibliographic Details
Main Authors: Aunjida Chawanarojnarit, Nirada Dhanesuan, Jittima Amie Luckanagul, Sorasun Rungsiyanont
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:Journal of Oral Biology and Craniofacial Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212426822000355
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846159542117728256
author Aunjida Chawanarojnarit
Nirada Dhanesuan
Jittima Amie Luckanagul
Sorasun Rungsiyanont
author_facet Aunjida Chawanarojnarit
Nirada Dhanesuan
Jittima Amie Luckanagul
Sorasun Rungsiyanont
author_sort Aunjida Chawanarojnarit
collection DOAJ
description One of the most important factors in a dental implant's success is an adequate quantity of supporting bone. However, there are still some limitations for the bone substitution material. Previous studies found that tobacco mosaic virus (TMV) had the potential for bone formation induction. The aim of this study was to evaluate the biocompatibility of TMV with primary human alveolar bone cells. Primary human alveolar bone cells were cultured on TMV coated substrates. Cell viability, alkaline phosphatase activity, calcium matrix mineralization forming ability, immunofluorescence staining for osteocalcin synthesis and cell morphology were assessed. The results showed that primary human alveolar bone cells cultured on the TMV coated substrates had a higher metabolic rate than the non-TMV coated control group at days 1, 3, 7 and 14. Moreover, the calcium deposition was positive and the alkaline phosphatase activity assay was found significantly greater than the control group at day 14 (p < 0.05). The osteocalcin protein synthesis was found in both the TMV coated substrates and the control group. The immunofluorescence study revealed that in the TMV coated substrates group, the cell morphology changed into a polygonal shape and aggregated more quickly than the control group. The present findings conclude that TMV is biocompatible with primary human alveolar bone cells and also shows osteoinduction potential.
format Article
id doaj-art-892b52b873f7435a9a99eb5b58dcd1d3
institution Kabale University
issn 2212-4268
language English
publishDate 2022-05-01
publisher Elsevier
record_format Article
series Journal of Oral Biology and Craniofacial Research
spelling doaj-art-892b52b873f7435a9a99eb5b58dcd1d32024-11-23T06:29:17ZengElsevierJournal of Oral Biology and Craniofacial Research2212-42682022-05-01123363369Biocompatibility study of tobacco mosaic virus nanoparticles on human alveolar bone cellsAunjida Chawanarojnarit0Nirada Dhanesuan1Jittima Amie Luckanagul2Sorasun Rungsiyanont3Department of Oral Surgery and Oral Medicine, Srinakharinwirot University, Bangkok, ThailandDepartment of Stomatology, Srinakharinwirot University, Bangkok, ThailandDepartment of Pharmaceutics and Industrial Pharmacy, Chulalongkorn University, Bangkok, ThailandDepartment of Oral Surgery and Oral Medicine, Srinakharinwirot University, Bangkok, Thailand; Corresponding author.One of the most important factors in a dental implant's success is an adequate quantity of supporting bone. However, there are still some limitations for the bone substitution material. Previous studies found that tobacco mosaic virus (TMV) had the potential for bone formation induction. The aim of this study was to evaluate the biocompatibility of TMV with primary human alveolar bone cells. Primary human alveolar bone cells were cultured on TMV coated substrates. Cell viability, alkaline phosphatase activity, calcium matrix mineralization forming ability, immunofluorescence staining for osteocalcin synthesis and cell morphology were assessed. The results showed that primary human alveolar bone cells cultured on the TMV coated substrates had a higher metabolic rate than the non-TMV coated control group at days 1, 3, 7 and 14. Moreover, the calcium deposition was positive and the alkaline phosphatase activity assay was found significantly greater than the control group at day 14 (p < 0.05). The osteocalcin protein synthesis was found in both the TMV coated substrates and the control group. The immunofluorescence study revealed that in the TMV coated substrates group, the cell morphology changed into a polygonal shape and aggregated more quickly than the control group. The present findings conclude that TMV is biocompatible with primary human alveolar bone cells and also shows osteoinduction potential.http://www.sciencedirect.com/science/article/pii/S2212426822000355BiocompatibilityTobacco mosaic virusAlveolar bone cell
spellingShingle Aunjida Chawanarojnarit
Nirada Dhanesuan
Jittima Amie Luckanagul
Sorasun Rungsiyanont
Biocompatibility study of tobacco mosaic virus nanoparticles on human alveolar bone cells
Journal of Oral Biology and Craniofacial Research
Biocompatibility
Tobacco mosaic virus
Alveolar bone cell
title Biocompatibility study of tobacco mosaic virus nanoparticles on human alveolar bone cells
title_full Biocompatibility study of tobacco mosaic virus nanoparticles on human alveolar bone cells
title_fullStr Biocompatibility study of tobacco mosaic virus nanoparticles on human alveolar bone cells
title_full_unstemmed Biocompatibility study of tobacco mosaic virus nanoparticles on human alveolar bone cells
title_short Biocompatibility study of tobacco mosaic virus nanoparticles on human alveolar bone cells
title_sort biocompatibility study of tobacco mosaic virus nanoparticles on human alveolar bone cells
topic Biocompatibility
Tobacco mosaic virus
Alveolar bone cell
url http://www.sciencedirect.com/science/article/pii/S2212426822000355
work_keys_str_mv AT aunjidachawanarojnarit biocompatibilitystudyoftobaccomosaicvirusnanoparticlesonhumanalveolarbonecells
AT niradadhanesuan biocompatibilitystudyoftobaccomosaicvirusnanoparticlesonhumanalveolarbonecells
AT jittimaamieluckanagul biocompatibilitystudyoftobaccomosaicvirusnanoparticlesonhumanalveolarbonecells
AT sorasunrungsiyanont biocompatibilitystudyoftobaccomosaicvirusnanoparticlesonhumanalveolarbonecells